News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Reflect Scientific, Inc. Develops Cold Chain Management Guidance for Pharmaceutical Industry


8/30/2011 9:03:23 AM

OREM, UT--(Marketwire - August 30, 2011) -

Reflect Scientific, Inc. (OTCBB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries, announced that the company has developed extensive cold chain management guidance using the Cryometrix ultra low temperature (ULT) freezers.

Cold chain management using the Cryometrix ULT freezers allows pharmaceutical and biotech companies to effectively control the product, through exacting temperature control, from manufacturing through delivery and final storage maintaining the integrity and quality throughout. "Reflect has gained the expertise through customer interaction to provide definitive information that will allow customers to achieve product through-put and quality that to date has not been available. Our guidance documents will be a tremendous tool for companies to make a purchasing decision on the Cryometrix ULT freezers," remarked Kim Boyce, CEO of Reflect Scientific.

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. For more information, visit www.reflectscientific.com.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.


Contact:

Thomas Tait
Vice President
719-357-5878


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES